Department of Neurology and Neuroscience

Clinical Trials

Study Title Albumin in Acute Stroke (ALIAS) Trial - Part 2: A Phase III Randomized Multicenter Clinical Trial of High-Dose Human Albumin Therapy for Neuroprotection in Acute Ischemic Stroke, NINDS# 2U01NS40406-04

Investigator Dr. Matthew E. Fink

Phone Number 212-746-4564

Study Title Hypothermia Treatment in Severe Subarachnoid Hemorrhage: A Pilot Study

Investigator Dr. Matthew E. Fink

Phone Number 212-746-4564

Study Title Effects of Coenzyme Q10 in Parkinson Disease - Phase III (QE3)

Investigator Dr. Melissa Nirenberg

Phone Number 212-746-2584

Study Title Healthcare Utilization and Functional Disability in Parkinson's Disease: Healthcare Utilization & Functional Disability in Parkinson's Disease

Investigator Dr. Melissa Nirenberg

Phone Number 212-746-2584

Study Title A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Three Doses of Aplindore MR (1, 3, and 6mg BID) in Patients with Early Parkinson Disease

Investigator Dr. Melissa Nirenberg

Phone Number 212-746-2584

Study Title Improved Strategies to Generate Human iPS Cells for Disease Modeling and Cell Therapy

Investigator Dr. Claire Henchcliffe

Phone Number 212-746-2584

Study Title Genetic and Environmental Risk Factors for Progressive Supranuclear Palsy (PSP)

Investigator Dr. Claire Henchcliffe

Phone Number 212-746-2584

Study Title Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS)

Investigator Dr. Dana Leifer

Study Title A 24-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel Group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally once Daily Versus Placebo in Patients with Relapsing-remitting Multiple Sclerosis, Study No. CFTY720D2309

Investigator Dr. Susan Gauthier

Phone Number 646-962-9800

Study Title An Open-Label Extension Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Seizures (E2080-A001-302)

Investigator Dr. Padmaja Kandula

Phone Number 212-746-2164

Study Title An open-label extension trial to determine safety and efficacy of long-term oral SPM 927 in patients with partial seizures

Investigator Dr. Douglas Labar

Phone Number 212-746-2359

Study Title Placebo-Controlled, Parallel-Group Study of Rufinamide Given as Adjunctive Therapy in Patients with Refractory Partial Seizures (Study E2080-A001-301)

Investigator Dr. Padmaja Kandula

Phone Number 212-746-2364

Study Title An international, double-blind, parallel-group, placebo-controlled, randomized study: evaluation of the efficacy and safety of brivaracetam in subjects (≥ 16 to 70 years old) with Partial Onset Seizures

Investigator Dr. Douglas Labar

Phone Number 212-746-2359

Study Title Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy (SANTE)

Investigator Dr. Douglas Labar

Phone Number 212-746-2359

Study Title Responsive Neurostimulator (RNS^TM) System Long-term Treatment Clinical Investigation (LTT-RNS)

Investigator Dr. Douglas Labare

Phone Number 212-746-2359

Study Title An open-label extension trial to determine tolerability and efficacy of long-term oral SPM 927 as adjunctive therapy in patients with partial seizures

Investigator Dr. Douglas Labar

Phone Number 212-746-2359

Study Title Environmental Epidemiology of Essential Tremor

Investigator Dr. Claire Henchcliffe

Phone Number 212-746-2584

Study Title Perioperative Course of PD Patients Undergoing Surgery: A Prospective Controlled Study

Investigator Dr. Claire Henchcliffe

Phone Number 212-746-2584

Study Title Deep brain stimulation surgery in Parkinson's Disease

Investigator Dr. Claire Henchcliffe

Phone Number 212-746-2584

Study Title Genotype-Phenotype Correlations in Parkinson's Disease